Babar Ghias

Chief Financial Officer, BioCryst Pharmaceuticals.

Companies

BioCryst PharmaceuticalsChief financial officer Jul 11, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

BioCryst Pharmaceuticals BCRX268,700 shares²$2.1M at $7.99Dec 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 17, 2025Granted 121,700 shares of BioCryst Pharmaceuticals²
Jul 24, 2025Granted 147,000 shares of BioCryst Pharmaceuticals³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBioCryst Pharmaceuticals, Chief financial officer
2
SEC EDGARBioCryst Pharmaceuticals shares after the filing of Dec 17, 2025
3
SEC EDGARForm 4 filed Jul 28, 2025